Elias Kouchakji

2021

In 2021, Elias Kouchakji earned a total compensation of $3.2M as Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance at FibroGen, a 10% increase compared to previous year.

Compensation breakdown

Option Awards$1,766,492
Salary$213,750
Stock Awards$1,102,608
Other$103,257
Total$3,186,107

Kouchakji received $1.8M in option awards, accounting for 55% of the total pay in 2021.

Kouchakji also received $213.8K in salary, $1.1M in stock awards and $103.3K in other compensation.

Rankings

In 2021, Elias Kouchakji's compensation ranked 4,199th out of 12,415 executives tracked by ExecPay. In other words, Kouchakji earned more than 66.2% of executives.

ClassificationRankingPercentile
All
4,199
out of 12,415
66th
Division
Manufacturing
1,727
out of 5,501
69th
Major group
Chemicals And Allied Products
717
out of 2,374
70th
Industry group
Drugs
639
out of 2,095
70th
Industry
Pharmaceutical Preparations
450
out of 1,542
71st

Pay ratio

Elias Kouchakji's Pay$3,186,107
Median Employee's Pay$174,414
Pay Ratio

18

to 1

In 2021, the annual total compensation of Elias Kouchakji was $3,186,107.

The annual total compensation of the median employee at FibroGen was $174,414.

The ratio of Elias Kouchakji's pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on April 28, 2022.

Kouchakji's colleagues

We found six more compensation records of executives who worked with Elias Kouchakji at FibroGen in 2021.

2021

Enrique Conterno

FibroGen

Chief Executive Officer

2021

Christine Chung

FibroGen

Senior Vice President, China Operations

2021

Mark Eisner

FibroGen

Chief Medical Officer

2021

Pat Cotroneo

FibroGen

Chief Financial Officer

2021

Thane Wettig

FibroGen

Chief Commercial Officer

2021

Juan Graham

FibroGen

Chief Financial Officer

News

In-depth

You may also like